Investment
Features
FeesSafety
Academy
More
Pluang+

Cellectis faces securities fraud probe after halting CAR-T therapy development, shares plunge 41%.

Market News
01 Oct 2026
PRNewsWire
View Source
Bearish
Cellectis faces securities fraud probe after halting CAR-T therapy development, shares plunge 41%.

Pomerantz LLP is investigating Cellectis S.A. for possible securities fraud after the company announced it would stop developing CAR-T cell therapies to focus on in vivo gene editing. This decision, citing financial constraints, led to a 40.97% drop in Cellectis's ADR price on September 14, 2026. The investigation aims to determine if Cellectis and its executives engaged in unlawful business practices. Investors affected by the share price fall are encouraged to contact Pomerantz LLP for potential class action participation.

Cellectis S.A. faced a 40.97% drop in its ADR price on September 14, 2026. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 01, 2026 20:52 WIB: out of 100 priced US health-sector stocks, 30 rose and 67 fell today. Notable movers include HIMS at USD 29.00 with a -2.65% change and 99% buy order activity, ENVB at USD 1.45 with a -2.36% change, and RXRX at USD 4.04 with a -2.18% change and 100% buy order activity on Pluang.

More News

Wells Fargo stock target raised to $95 on strong Q3 earnings forecast and Fed regulatory easing

Wells Fargo stock target raised to $95 on strong Q3 earnings forecast and Fed regulatory easing

An analyst at Truist Financial raised Wells Fargo's price target to $95, suggesting a 20.74% upside from its current price. This optimism is driven by expected strong third-quarter earnings of $1.85 per share and $22.34 billion in revenue, surpassing...

Analyst Insights
Bullish
2 hours ago
Oklo advances carbon-free energy with new reactors and $1.68B nuclear fuel recycling plan

Oklo advances carbon-free energy with new reactors and $1.68B nuclear fuel recycling plan

Oklo is developing advanced fast-fission reactors to power future data centers and industrial hubs, aiming to lead in carbon-free energy. Piper Sandler reaffirmed an "Overweight" rating on the stock, reflecting confidence in Oklo's growth prospects. ...

Market News
Bullish
2 hours ago
Nike earnings expected to show decline amid 80% stock drop and cautious market sentiment

Nike earnings expected to show decline amid 80% stock drop and cautious market sentiment

Nike is set to release its quarterly earnings on October 1, 2026, with analysts forecasting an EPS of $0.44 and revenue of $11.32 billion, both down from last year. The company's stock has fallen 80% this year, hitting 13-year lows, reflecting a chal...

Company Fundamentals
Bearish
2 hours ago
Lamb Weston expects Q3 EPS of $0.59 on stable $1.65B revenue, driven by cost savings and efficiency gains.

Lamb Weston expects Q3 EPS of $0.59 on stable $1.65B revenue, driven by cost savings and efficiency gains.

Lamb Weston is set to report Q3 earnings with analysts forecasting an EPS of $0.59, down from $0.74 last year, and revenue around $1.65 billion, nearly flat compared to the prior year. The company’s "Focus to Win" strategy has generated over $100 mil...

Company Fundamentals
Neutral
3 hours ago
Trump's meme coin holders invited to gala dinner with prizes including 18K gold watches

Trump's meme coin holders invited to gala dinner with prizes including 18K gold watches

Donald Trump announced a gala dinner for the top 185 holders of his Official Trump (TRUMP) meme coin at Trump National, Washington, DC, on November 22, 2026. The event features a competition on a time-weighted leaderboard, with top prizes including 1...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App